z-logo
Premium
Identification of the Subunit Structure of Rat Pineal Adrenergic Receptors by Photoaffinity Labeling
Author(s) -
Dickinson Kenneth E. J.,
LeebLundberg L. M. Fredrik,
Strasser Ruth H.,
Caron Marc G.,
Lefkowitz Robert J.
Publication year - 1986
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1986.tb00630.x
Subject(s) - receptor , photoaffinity labeling , dissociation constant , agonist , peptide , adrenergic receptor , biochemistry , chemistry , protein subunit , biology , medicine , endocrinology , microbiology and biotechnology , stereochemistry , gene
The adrenergic receptors of rat pineal gland were investigated using radiolabeled ligand binding and photoaffinity labeling techniques. 125 I‐2‐[β‐(4‐hydroxyphenyl)ethylaminomethyl]tetralone ( 125 I‐HEAT) and 125 I‐cyanopindolol ( 125 I‐CYP) labeled specific sites on rat pineal gland membranes with equilibrium dissociation constants ( K D ) of 48 (±5) p M and 30 (±5) p M , respectively. Binding site maxima were 481 (±63) and 1,020 (±85) fmol/mg protein. The sites labeled by 125 I‐HEAT had the pharmacological characteristics of α 1 ‐adrenergic receptors. 125 I‐CYP‐labeled β‐adrenergic receptors were characterized as a homogeneous population of β 1 ‐adrenergic receptors. The α 1 ‐ and β 1 ‐adrenergic receptors were covalently labeled with the specific photoaffinity probes 4‐amino‐6,7‐dimethoxy‐2‐{4‐[5‐(4‐azido‐3‐[ 125 I]iodo‐phenyl) pentanoyl]‐1‐piperazinyl}quinazoline ( 125 I‐APDQ) and 125 I‐p‐azidobenzylcarazolol ( 125 I‐pABC). 125 I‐APDQ labeled an α 1 ‐adrenergic receptor peptide of M r = 74,000 (±4,000), which was similar to peptides labeled in rat cerebral cortex, liver, and spleen. 125 I‐pABC labeled a single β 1 ‐adrenergic receptor peptide with a M r = 42,000 (±1,500), which differed from the 60–65,000 peptide commonly seen in mammalian tissues. Possible reasons for these differences are discussed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here